PATENT CLAIM ANALYSIS

Application Number: 15748034
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["435", "167000"]

Abstract:
Described are HIV kinase variants showing an improved activity in converting 3-hydroxyisovalerate (HIV) into 3-phosphonoxyisovalerate (PIV), methods for the production of PIV using such enzyme variants as well as methods for the production isobutene in a subsequent reaction.

Claim (Index 6):
A nucleic acid molecule encoding the HIV kinase variant of  claim 1 .

Metadata:
- Claim Count in Document: 18.0
- Percentile: 86.0
- Lexical Diversity: 1.33333
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15108917', '14891665', '15526248', '13880042', '14390774']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5697682553466662
- 35 USC 102 Novelty (BERT): 0.5310185349711052
- Combined Prediction Score: 0.56589328330911
- Mean Citation Score: 237.149332
- Max Citation Score: 337.52695
- Similarity Product: 244.961058861649

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test